Two professors and three additional alumni recognized for “dreaming up solutions to global challenges — advancing health, sustainability, and human connection.”
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
To make the new entertainment venue a reality, Jared Miller ’98, MBA ’03, SM ’03 assembled a team that reflected his experience at MIT.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT chemical engineers create a zwitterionic hydrogel system for single-step water treatment with minimal environmental footprint.
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.
MIT researchers find that in mice and human cell cultures, lipid nanoparticles can deliver a potential therapy for inflammation in the brain, a prominent symptom in Alzheimer’s.
Using generative AI, MIT chemical engineers and chemists created a model that can predict the structures formed when a chemical reaction reaches its point of no return.
Human volunteers will soon begin receiving an HIV vaccine that contains an adjuvant developed in Irvine’s lab, which helps to boost B cell responses to the vaccine.
Anna Kwon and Nicole Doering are the first undergraduate students to receive Jane Matlaw Environmental Champion Awards.